100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR, FLORHAM PARK, NJ
Shareholder Meeting Held; CBIZ CPAs P.C. Appointed as Auditor for 2026
Enters into Share Purchase and Collaboration Agreement with Dalian Wanchunbulin Pharmaceuticals Ltd.
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
BeyondSpring Gets FDA Fast Track for Plinabulin in NSCLC
Annual Report to Security Holders
Reports Second-Quarter 2026 Financial Results and Provides Corporate Update
Amended material disclosure
Q2
Q1
FY 2025
Q3
FY 2024
Annual and Transition Report of Foreign Private Issuers
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Amended Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Post-Effective Amendment to Registration Statement
Correspondence
Submission Upload